Literature DB >> 20090568

Molecular identification of bloodstream pathogens in patients presenting to the emergency department with suspected sepsis.

Manuela Avolio1, Paola Diamante, Silvio Zamparo, Maria Luisa Modolo, Shamanta Grosso, Paola Zigante, Nilla Tosoni, Rita De Rosa, Paola Stano, Alessandro Camporese.   

Abstract

The rapid detection of pathogens in blood is critical for a favorable outcome of patients with suspected sepsis. Although blood culture (BC) is considered the criterion standard for diagnosis of bloodstream infection, it often takes several days to detect the causative organism. In this study, we compared BC with a commercially available multiplex real-time polymerase chain reaction (PCR) assay to detect bacteria and fungi in blood samples from 144 patients admitted to the emergency department with suspected sepsis. Of 144 blood samples examined, 91 (63%) were negative by both methods and 53 (37%) were positive by at least one of the two methods. In 30 among all positive cases (56.6%),both methods identified the same organisms, in 13 cases (24.5%), BC identified organisms not detected by real-time PCR,and in 10 cases (18.9%), SeptiFast PCR assay gave positive results, whereas the BC was negative. In this study, we wished to compare SeptiFast results obtained by standard procedures, but future clinical studies are necessary to define SeptiFast PCR as support for BC in the early diagnosis of severe bloodstream infections.

Entities:  

Mesh:

Year:  2010        PMID: 20090568     DOI: 10.1097/SHK.0b013e3181d49299

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  22 in total

1.  Non-culture-based methods to diagnose bloodstream infection: Does it work?

Authors:  Miha Skvarc; David Stubljar; Petra Rogina; Achim J Kaasch
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-06-05

Review 2.  Accuracy of LightCycler(®) SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review and meta-analysis.

Authors:  Paul Dark; Bronagh Blackwood; Simon Gates; Danny McAuley; Gavin D Perkins; Ronan McMullan; Claire Wilson; Daniel Graham; Kate Timms; Geoffrey Warhurst
Journal:  Intensive Care Med       Date:  2014-11-22       Impact factor: 17.440

3.  Molecular diagnosis of sepsis: New aspects and recent developments.

Authors:  O Liesenfeld; L Lehman; K-P Hunfeld; G Kost
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

Review 4.  Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view.

Authors:  Mathias W Pletz; Nele Wellinghausen; Tobias Welte
Journal:  Intensive Care Med       Date:  2011-05-15       Impact factor: 17.440

Review 5.  Emerging Technologies for Molecular Diagnosis of Sepsis.

Authors:  Mridu Sinha; Julietta Jupe; Hannah Mack; Todd P Coleman; Shelley M Lawrence; Stephanie I Fraley
Journal:  Clin Microbiol Rev       Date:  2018-02-28       Impact factor: 26.132

6.  Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infections.

Authors:  P Josefson; K Strålin; A Ohlin; T Ennefors; B Dragsten; L Andersson; H Fredlund; P Mölling; P Olcén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-04       Impact factor: 3.267

7.  Multiplex polymerase chain reaction pathogen detection in patients with suspected septicemia after trauma, emergency, and burn surgery.

Authors:  Nam K Tran; David H Wisner; Timothy E Albertson; Stuart Cohen; David Greenhalgh; Tina L Palmieri; Christopher Polage; Gerald J Kost
Journal:  Surgery       Date:  2011-10-05       Impact factor: 3.982

8.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Structured oligonucleotides for target indexing to allow single-vessel PCR amplification and solid support microarray hybridization.

Authors:  Laurie D Girard; Karel Boissinot; Régis Peytavi; Maurice Boissinot; Michel G Bergeron
Journal:  Analyst       Date:  2015-02-07       Impact factor: 4.616

Review 10.  Commercial multiplex technologies for the microbiological diagnosis of sepsis.

Authors:  Evan E Lebovitz; Peter D Burbelo
Journal:  Mol Diagn Ther       Date:  2013-08       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.